Identifying and validating biomarkers for Alzheimer's disease

Humpel, Christian·2011·Trends in Biotechnology
DOI 10.1016/j.tibtech.2010.09.007

Cited by (484)

Items 401–484 of 484

  1. Association between Alzheimer’s disease, MAPT gene mutation and some biochemical biomarkers
    Aysenur Sen, Orçun Avşar, Sinan Eliaçık, Funda Uysal Tan · 2024 · Nucleosides Nucleotides & Nucleic Acids
  2. Neurodegenerative Diseases and Bioimaging of Peripheral Neurotransmitters Mediated Biochemical Parameters
    Zuber Peermohammed Shaikh, Satish Balkrishna Bhise · 2025 · IGI Global eBooks
  3. Potential application of nanotechnology in Type-3 diabetes: Bridging insulin resistance and neurodegeneration
    Adrija Ghosh, Sresha Sarkar, Debashmita Mandal, Jonathan Tersur Orasugh, Suprakas Sinha Ray, Dipankar Chattopadhyay · 2025 · Nano Trends
  4. A systematic review and meta-analysis of metalloproteinases in patients with Alzheimer's disease and mild cognitive impairment
    Gillian A McNaugher, Leah McColgan, Mia Church, Paula L. McClean, David S. Gibson, Elaine K. Murray, Sophie Coyle, Victoria McGilligan · 2026 · Journal of Alzheimer s Disease
  5. Spectrophotometer measurements to characterize conformational state of the proteins: p53 analysis
    Saad Abdullah, Mauro Serpelloni, Sarah Tonello, Emilio Sardini, Giulia Abate, Daniela Letizia Uberti · 2018 · IEEE International Symposium on Medical Measurements and Applications (MeMeA)
  6. Drug Delivery Strategies in Alzheimer’s Disease
    Govind Hake, Akshada S. Mhaske, Rahul Shukla · 2023 · Springer eBooks
  7. Advances in Therapies and Scope for Personalized Medicine in Alzheimer’s Disease
    Hosakere N Ravishankar, A. K. Dutta, Alisha G. Lewis, Amogh Mohan · 2016 · Personalized Medicine
  8. INFECTION-ASSOCIATED DEMENTIA
    Herpan Syafii Harahap, Sri Budhi Rianawati · 2015 · MNJ (Malang Neurology Journal)
  9. Fiber-enhanced Raman spectroscopy as a tool for an early detection of Alzheimer's disease biomarkers
    Pinkie Jacob Eravuchira, Martina Banchelli, Cristiano D’Andrea, Marella de Angelis, Paolo Matteini, Israel Gannot · 2019 · Optical Fibers and Sensors for Medical Diagnostics, Treatment, and Environmental Applications
  10. Glymphatic Efficiency is a Critical Factor for Using Abnormal Tau in Peripheral Tissues as Biomarker for Alzheimer’s Disease
    Ya‐Huan Lou · 2018 · Biomarkers and Applications
  11. Gambir catechins modulates amyloid-β concentration in cerebrospinal fluid of Alzheimer’s model rat
    Ulya Uti Fasrini, Nur Indrawaty Lipoeto · 2021 · IOP Conference Series Earth and Environmental Science
  12. Mining relations between neuropsychological data to characterize Alzheimer’s disease
    Germán A. Pabón, Diana L. Giraldo, Eduardo Romero Castro · 2021 · International Symposium on Medical Information Processing and Analysis (SIPAIM)
  13. Nervenzellen retten oder ersetzen – welche Strategie ist erfolgreicher?
    Lars P. Klimaschewski · 2021 · Springer eBooks
  14. Beneficial Effects of Anthocyanins on Nervous System
    Bin Li, Li Wang, Weibin Bai, Wei Chen, Fang Chen, Chi Shu · 2021 · Springer eBooks
  15. Machine Learning Computational Framework for Alzheimer’s Disease Stages Classification
    Carlos Theran, Yohn Jairo Parra Bautista, Victor Adankai, Richard Aló · 2022 · Lecture notes in networks and systems
  16. "I don't recognize myself", personality characteristics in subjective cognitive impairment and mild cognitive impairment
    Birgitta Ausén · 2013 · Figshare
  17. EDITORIAL
    Jared M. Campbell · 2015 · The JBI Database of Systematic Reviews and Implementation Reports
  18. Stable and predictive functional domain selection with application to brain images
    Park, Ah Yeon, John A. D. Aston, Frédéric Ferraty · 2016 · arXiv (Cornell University)
  19. Translational Application of Biomarkers
    R. Bakhtiar · 2017
  20. Meta-microRNAs as potential noninvasive markers for early diagnosis of Alzheimer’s disease
    Ning Jiang, Can‐Jun Ruan, Xiaorui Cheng, Lu‐Ning Wang, Jiping Tan, Weishan Wang, Fang Liu, Wenxia Zhou, Yongxiang Zhang · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  21. Das Zentralnervensystem
    Ludger Rensing, Volkhard Rippe · 2013 · Springer eBooks
  22. Individualized Gaussian Process-based Prediction of Memory Performance and Biomarker Status in Ageing and Alzheimer’s disease
    Aditya Nemali, Niklas Vockert, David Berron, Anne Maaß, Renat Yakupov, Oliver Peters, Daria Gref, Nicoleta Carmen Cosma, Lukas Preis, Josef Priller et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Towards Early Diagnosis and Screening of Alzheimer’s Disease Using Frequency Locked Whispering Gallery Mode Microtoroid Biosensors
    Adley Nathanael Gin, Phuong-Diem Nguyen, Geidy E. Serrano, Gene E. Alexander, Judith Su · 2024 · Research Square
  24. La aplicación de biomarcadores a la búsqueda de nuevas farmacoterapias para el tratamiento de la enfermedad de Alzheimer
    Alcibiades E. Villarreal, Lee Anne Gómez, Shantal A. Grajales, Rosa Arrue, Gabriela Carrillo-Pujol, Frank Ferro, K. S. Jagannatha Rao, Gabrielle B. Britton · 2014
  25. Cytogenetic alterations in peripheral cells of Alzheimer’s disease patients
    Bosiljka Plećaš‐Solarović, Ninoslav Djelić, Vladan Bajić, Lada Živković, Biljana Spremo‐Potparević · 2014 · Genetika
  26. New Frontiers in Alzheimer's Disease Diagnosis
    Franc Llorens, Sabine Nuhn, Christoph Peter, Inga Zerr, Katharina Stoeck · 2015 · InTech eBooks
  27. BACE1 Inhibitors: Attractive Therapeutics for Alzheimer’s Disease
    Boris Decourt, Mimi P Macias, M. Sabbagh, A. Adem · 2014 · Elsevier eBooks
  28. Estudio clínico, neurocognitivo y análisis espectral del electroencefalograma en pacientes con enfermedad de Alzheimer
    Alicia Carreres Rodríguez · 2015
  29. Biomarkers in Alzheimer’s Disease: From Pathogenic Initiation to Downstream Outcomes
    Sun-Ho Han, Jong‐Chan Park, Inhee Mook‐Jung · 2015 · Springer eBooks
  30. Gene therapy for Alzheimer's disease: Characterising lentivirus and adeno-associated virus spread from the adult mouse hippocampus
    Isaiah Cheong · 2016 · Otago University Research Archive (University of Otago)
  31. Imaging mouse models of neurodegeneration using multi-parametric MRI
    HE Holmes · 2015 · UCL Discovery (University College London)
  32. Biomarkers and Neurodegenerative Diseases: Promising Inroads Toward a Distant Goal
    Richard Rubenstein · 2014 · CRC Press eBooks
  33. A contribuição de estudos populacionais em idosos saudáveis: base de dados genômicos, compreensão do envelhecimento e lateralidade cerebral
    Michel Satya Naslavsky · 2016 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  34. Estandarización de aspectos preanalíticos para el estudio de biomarcadores de la enfermedad de Alzheimer en el líquido cefalorraquídeo
    Alejandro Gella, Albert Lladó Plarrumaní, José Luís Molinuevo · 2016 · Revista del Laboratorio Clínico
  35. The Role of Chromatography in Alzheimer’s Disease Drug Discovery
    Eli Grushka, Nelu Grinberg · 2016 · CRC Press eBooks
  36. Experimental and computational studies on sensing of DNA damage in Alzheimer's disease
    Bayu Tri Murti · 2017
  37. Charakterisierung von Prädiktoren rapid-progressiver Verläufe des M. Alzheimer
    Thomas Bartlau · 2016
  38. Development of Biochip Sensors for Blood Biomarkers Specific to Alzheimer’s Disease Diagnostics
    Suhee Kim, Sang‐Hyuk Lee, Hye Jin Lee · 2017 · Applied Chemistry for Engineering
  39. A Novel Technique to Characterize Conformational State of the Proteins: p53 Analysis
    Saad Abdullah, Mauro Serpelloni, Giulia Abate, Daniela Letizia Uberti · 2019 · Lecture notes in electrical engineering
  40. Characterization of high-density prion protein oligomers in rapid progressive and sporadic Alzheimer’s disease
    Mohsin Shafiq · 2019
  41. The relation between human biomarkers and oxidative stress in Alzheimer’s disease, novel in vivo experimental modelling possibilities
    Zita Galik-Olah · 2018
  42. Amyloid beta: from pre-analytical factors to disease mechanisms
    Jamie Toombs · 2019 · UCL Discovery (University College London)
  43. a Circulating cell free mitochondrial DNA copy number variation in neurodegenerative disease
    Hannah Lowes · 2018
  44. Potential of Blood- and CSF-Based Biomarkers for Alzheimer’s Disease Diagnostics
    Eric Luria Goldwaser, Robert G. Nagele · 2020 · Oxford University Press eBooks
  45. Biomarkers of Parkinson’s Disease
    Fang Fang, Tessandra Stewart, Jing Zhang · 2015 · Biomarkers in disease
  46. Clinical Validation of Neuronal Pentraxin Receptor as a Candidate Biomarker for Alzheimer’s Disease
    Bryant Lim · 2020 · TSpace (University of Toronto)
  47. EXAMINING NEUROLOGICAL AND NEURODEGENERATIVE DISORDERS RELATED TO AGING AND ELDERLY
    Elcin Huseyn · 2021
  48. ADAM10 as a biomarker for Alzheimer’s disease
    Mariana Luciano de Almeida, Izabela Pereira Vatanabe, Patrícia Regina Manzine, Rafaela Peron, Carlos Roberto Bueno Júnior, Márcia R. Cominetti · 2021 · Elsevier eBooks
  49. Development of electrochemical immunosensors for detection of Tau protein : computational and experimental studies
    Calvin Carl Harilal · 2019
  50. Biomarkers of Parkinson’s Disease
    Fang Fang, Tessandra Stewart, Jing Zhang · 2014 · Springer eBooks
  51. Decoding the Epigenome of Neuronal Networks in Health and Disease
    Gaurav Jain · 2019
  52. Progress of Nanotechnology-Based Detection and Treatment of Alzheimer’s Disease Biomarkers
    Yashwant Rao Singh, Anupam Shukla, Sudip Kumar Pattanayek · 2022 · Springer eBooks
  53. Western Agarose Native GeELution (WANGEL) with beta-amyloid and tau: Novel method to elute proteins or peptides using native agarose gels followed by Lumipulse assay
    Dhwani S. Korde, Christian Humpel · 2022 · MethodsX
  54. The Role of Chromatography in Alzheimer’s Disease Drug Discovery
    2016 · Advances in chromatography
  55. Biomarkers in the cerebrospinal fluid during pregnancy
    Wolfgang Lederer, Christian Humpel · 2022 · Elsevier eBooks
  56. Saving or Replacing Nerve Cells: Which Strategy is More Successful?
    Lars P. Klimaschewski · 2022 · Springer eBooks
  57. Development of ATR-FTIR spectroscopy for the diagnosis of Alzheimer’s disease using oral buccal cells
    Maria Paraskevaidi, Salman Karim, Marfran C. D. Santos, Kássio M. G. Lima, StJohn Crean · 2023 · Research Square
  58. Diagnosing Alzheimer’s Disease using SPSS statistical analysis
    2018 · REST Journal on Emerging trends in Modelling and Manufacturing
  59. Early Testing of Alzheimer's using Biomarkers
    Kiranpreet Utal, Jothsna Kethar · 2022 · Journal of Student Research
  60. Lipocalin 2 als liquor und plasmabasierter Biomarker bei vaskulärer Enzephalopathie: Assoziationen mit klinischen Merkmalen und verschiedenen Formen der vaskulären Demenz
    Hanna Lindemann · 2023
  61. Using Angular Light Scattering to Measure Protein Aggregation
    Cassidy Vik, Lani Espinel, Ashley E. Cannaday · 2023 · Optics in the Life Sciences
  62. A review on the β-amyloid precipitation hypothesis
    Bohan Li · 2023 · Theoretical and Natural Science
  63. Early Event-Related Potential components as potential biomarkers for Alzheimer's Disease and their relationship with attentional capacity.
    Duncan Morison · 2023
  64. Biomarkers for Alzheimer’s Disease
    Mareechika Gaddam, Esther Rani Motamarri, Abha Sharma · 2023 · Springer eBooks
  65. Novel Treatment for Alzheimer’s Disease: Tapping the Somatostatin-evoked Aβ Catabolism via α-endosulfine-KATP Channel Pathway
    Ryan Varghese, Gargi Digholkar, Abha Deshpande, Dileep Kumar · 2023 · BENTHAM SCIENCE PUBLISHERS eBooks
  66. Clinical Presentation of Alzheimer Disease (ad): a hospital based observational study.
    Abdul Rauoof Malik, Muhammad Athar Khan, Bushra Ammad Taimuri, Muhammad Azhar Hussain, Sadaf Nasir, Aisha Aisha · 2021 · JMMC
  67. In silico analysis of Chlorophytum borivilianum phytocompounds as a multi-targeted directed ligand (MTDL) against type 2 diabetes mellitus-induced Alzheimer’s disease
    Kanika Khoba, Shivani Kumar, Ram Singh Purty · 2025 · Natural Product Research
  68. Bridging language markers and pathology: correlations between digital speech measures and surrogate CSF biomarkers in Alzheimer's disease
    Yijiang Pang, Liu Chen, Hiroko Hayama Dodge, Jiayu Zhou · 2026 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  69. Social, ethical, and epistemological aspects of dementia prevention: the three-country BEAD study
    Annette Leibing, Silke Schicktanz, Alessandro Blasimme · 2025 · Geriatrics Gerontology and Aging
  70. Additional file 1 of Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer’s disease
    Longfei Jia, Zhu, Min, Yang, Jianwei, Yana Pang, Wang, Qi, Li, Ying, Li, Tingting, Li, Fangyu, Qigeng Wang, Li, Yan et al. · 2021 · Figshare
  71. Additional file 1 of High affinity of β-amyloid proteins to cerebral capillaries: implications in chronic lead exposure-induced neurotoxicity in rats
    Luke L. Liu, Shen, Xiaoli, Huiying Gu, Zhao, Gang, Yansheng Du, Wei Zheng · 2024 · Figshare
  72. Additional file 1 of A circular RNA blood panel that differentiates Alzheimer’s disease from other dementia types
    Ren, Ziye, Changbiao Chu, Yana Pang, Cai, Huimin, Longfei Jia · 2022 · Figshare
  73. Additional file 2 of Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer’s disease
    Longfei Jia, Zhu, Min, Yang, Jianwei, Yana Pang, Wang, Qi, Li, Ying, Li, Tingting, Li, Fangyu, Qigeng Wang, Li, Yan et al. · 2021 · Figshare
  74. APOE, Biomarkers, and Proteogenomics in Alzheimer’s Disease
    Jéssica Diniz Pereira, Jéssica Abdo Gonçalves Tosatti, Karina Braga Gomes · 2026 · Springer eBooks
  75. Plasma phospho-tau 217 outperforms plasma phospho-tau 181 analyzed with Lumipulse in detecting Alzheimer’s dementia in a real-world memory clinic population
    Michaela Defrancesco, Elke Ruth Gizewski, Ruth Steiger, Irene Johanna Virgolini, Alexander Stephan Kroiss, Timo A. Schurr, Jan Paul Görtz, Josef Marksteiner, Alex Hofer, Christian Humpel · 2026 · Frontiers in Aging Neuroscience
  76. Identification of causally linked blood biomarkers for Alzheimer's disease via reverse transcriptome-wide Mendelian randomization
    Zimo Li, Dong Wang, Fei Xia, Yuchen Liu, Yunyi Liu · 2026 · Journal of Alzheimer s Disease
  77. Microfluidic magnetic fluidized bed for bioanalytical applications
    Iago Pereiro · 2016
  78. An innovative approach for magnetic solid supports handling in droplet microfluidics
    Marco Serra · 2018
  79. Magnetic fluidized beds in microfluidic : application to ultrasensitive detection for bioanalysis
    Lucile Alexandre · 2018
  80. 3S-HS et HS3ST2 dans les macrophages humains : implication dans le diagnostic de la maladie d'Alzheimer
    Oulfa Ben Abdelouahab · 2021 · theses.fr (ABES)
  81. Exploration de nouveaux biomarqueurs plasmatiques pour le diagnostic de la maladie d’Alzheimer
    Emilie Rossi · 2021
  82. APOE, Biomarkers, and Proteogenomics in Alzheimer’s Disease
    Jéssica Diniz Pereira, Jéssica Abdo Gonçalves Tosatti, Karina Braga Gomes · 2026 · Springer eBooks
  83. Cerebral perfusion correlates of domain-specific cognitive function in Alzheimer's disease and dementia with Lewy bodies
    Yume Koizumi, Yoshikazu Nakano, Mitsuyoshi Tamura, Kousuke Yamagishi, Yutaro Suzuki, Michiko Izumi, Yoshikazu Chishiki, Kenta Osawa, Shogo Furukawa, Ai Ishikawa et al. · 2026 · Journal of Alzheimer s Disease
  84. BindingDB Entry 50009606: Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases.
    BindingDB · 2021 · UC San Diego